REVI PROCTOSCOPE

Rectoscope with illumination and high-resolution camera, sterilisable 
that transmits images in real time, via cable or wifi to any electronic device. 
electronic device. This allows visualisation of the anastomosis up to 15 cm. 
of the anastomosis up to 15 cm of anal margin, thanks to the anatomical curvature of its 
anatomical design, as well as other intraluminal lesions of the ano-rectal canal for diagnosis 
ano-rectal canal for diagnosis, treatment, intraoperative and/or outpatient 
outpatient.

Technological offer
   

UTERINE MANIPULATOR FOR MINIMALLY INVASIVE SURGERY

The researchers' objective is that the patented surgical instrument be used for laparoscopic abdominal hysterectomy, with a vacuum clamping system to the vacuum clamping system to the cervix by means of a system of interchangeable cups of different sizes interchangeable cups of different sizes, so as not to injure the initial tumour and to minimise the damage minimises the damage caused by the manipulation of the uterus and, therefore, the migration of potential migration of possible carcinogenic agents.
 

Technological offer

 

           
 
   

CARIES RISK DIAGNOSTIC TEST

With a simple saliva sample, the SIMMA test predicts with a reliability of 98% the risk of each person developing caries, and the cause of it, something that differentiates it from other tests on the market. By measuring different "biomarkers", the invention allows applying a preventive personalized treatment to each individual.

Technological offer

  

NEW INTRAVITREAL TREATMENT FOR DIABETIC RETINOPATHY

Diabetic retinopathy is a leading cause of blindness worldwide. The present invention formulates a new intravitreal treatment that inhibits the inflammatory underlying problem that triggers the disease. It is a therapeutic option with an active ingredient which has demonstrated efficacy in experimental phase and improves the cost/ effectiveness of current treatments.

Technological offer

MEDICATION DISPENSING NIPPLE FOR INFANTS

The administration of medication to infants usually involves dispensing problems and stress due to the rejection of the baby. This dispensing nipple, applicable to standard baby bottles, enables the administration of medication in a controlled manner, knowing exactly the amount of medication that the infant has swallowed, camouflaging the taste of it and controlling the rate of drug delivery.

Technological offer 

PRIMERS FOR DETECTION AND TYPING OF CARBAPENEMASE-PRODUCING BACTERIAL STRAINS, DETECTION KIT AND METHOD

FISABIO Foundation has developed a test that, with a simple blood patient sample and in a single reaction, allows the diagnosis of multiresistant bacteria to next generation antibiotics. Its use in clinical practice, on the one hand, will optimize the antibiotic treatment of patients and, on the other, the early detection and control of nosocomial outbreaks of infections

Technological offer

Licensed technology

NEW ANTICARIES PROBIOTICS

The Department of Genomics and Health of FISABIO has discovered a new bacterial species, unknown until now to the scientific community, named Streptococcus dentisani. This new microorganism acts as a shield against caries-causing bacteria, so it can be used as probiotic product for treatment and/or prevention, helping to reduce the incidence of this infectious disease in the population.

Technological offer

Licensed technology

PERCUTANEOUS ACCESS SHEATH FOR THE SURGICAL TREATMENT OF URINARY LITHIASIS

Urinary lithiasis or urinary calculi is a disease with a high incidence worldwide. Although its surgical treatment has improved by the use of percutaneous access sheaths, they still present disadvantages for both the patient and the professional. The present invention results in an improvement of this technique, preventing the migration of the sheath into the patient, reducing the friction with the nephroscope and allowing easy introduction of surgical material.

Technological offer

SAFETY AGENDA MOBILE APP (SAMA) 

Adverse events (AE) are a reality in usual medical assistance. SAMA is a mobile app designed to improve patient safety as a strategic tool of the own health centre. It helps managers and professionals in the management of interventions on patient safety which they are directly responsible and promotes a proactive culture in patient safety.

Technological offer
METHOD FOR THE DIAGNOSIS AND/OR PROGNOSIS OF ALZHEIMER DISEASE


Even though Alzheimer disease (AD) is the most common form of dementia, there are not yet biomarkers that enable early detection. The present invention addresses this issue by detecting preselinin 1 (PS1) in the cerebrospinal fluid as diagnostic and/or pronostic marker in the development and progression of AD, even allowing treatment monitoring.

Technological offer
NEW VAGINAL PROSTHESIS


The product consists of a prosthesis intended to be placed temporarily in the space defined between the bladder and rectum of women with vaginal agenesis and in sex change interventions, to create an artificial vaginal cavity or neovagina with a suitable luminal diameter following the surgical technique known as McIndoe.

 

Technological offer

Licensed technology

DURAL SEALING SYSTEM

Post-Dural Puncture Headache (PDPH) is a prevalent complication of epidural anaesthesia worldwide, generated by a cerebrospinal fluid (CSF) leak through an unintended opening of dura mater. At present, there is not an effective treatment for PDPH. This instantaneous new dural sealing system, which allows repair the lesion at the same time when it is caused, is designed to prevent the onset of PDPH in order to avoid further patient suffering, as well as reducing costs derived from the clinical problem.
 

Technological offer
   

APPTIVAMENT

We introduce an app for mobile devices with the aim of contributing to the functional and cognitive stimulation of patients with Alzheimer and other neurodegenerative diseases, using game based technology, and with especial attention to activities of daily living, memory recovering therapies and personalized music therapy.
 

Technological offer
   
HER2 AS A GENOMIC PREDICTOR IN HER2+ BREAST CANCER


The present invention allows predicting the degree of efficacy of different therapies in HER2+ breast cancer patients. The method uses an in vitro marker that helps the oncologist decide the most appropriate therapy, and particularly in the possibility of avoiding chemotherapy in the early stages of this disease.

 

Technological offer

Licensed technology
   
TUMEDICINA


TuMedicina is an application for smartphones and tablets as an electronic prospect-like that transforms the barcodes and QR codes into verbal instructions. All you have to do is place the medication box on the screen of the mobile device to detect the code and it issues a voice message with the information of the medicine. The information can be adapted to the patient, allowing their self-management and improving their safety, especially in situations of polymedication and mainly in elderly patients. In addition, it may be especially useful for the family and caregivers, or even as a support tool for their usual pharmacist.

 

Technological offer
   
PLATFORM FOR EARLY DIAGNOSIS OF STEREOPSIS DISORDERS


The designed platform offers a system to measure the depth perception (in mm) of a patient based on artificial vision techniques, and thus the platform is able to diagnose and monitor patients with vision problems in stereo and stereoscopic acuity not det ectable by traditional systems.

Technological offer
   
STABILIZED SCAPHOID PARTIAL PROSTHESIS


The new prosthesis simulates the dimensions and morphology of the anatomical scaphoid and has been designed in three sizes that adapt to any patient with the aim of relieving pain and maintaining the widest range of mobility and strength possible, and therefore will not lead in the future to collapse and carpal arthrosis.

Technological offer
PEPTIDE FOR THE PREVENTION AND TREATMENT OF INFLUENZA AND OTHER RESPIRATORY VIRAL INFECTIONS
 
 
New peptide of human origin for the prevention and treatment of the influenza virus, as well as a method to determine in vitro the level of said peptide, which can be a risk factor for developing influenza in an individual. The project allows the development of a kit to determine the concentration of said peptide from a saliva sample, which would allow the taking of preventive measures if necessary.
 
 

PREBIOTIC AND PROBIOTIC TREATMENT TO REDUCE ORAL DYSBIOSIS AND PREVENT OR TREAT PERIODONTITIS, HALITOSIS AND DENTAL CAVITIES

This patent will be the origin of a new complete line of oral health products and it will open the way to the development of prebiotics like natural active ingredients complementary to fluoride and alternative to oral antiseptic. Another protected product is an anti-halitosis pill capable of slowing down the production of gas that causes bad breath for 6 hours.

 

Technological offer

SOFTWARE TO SUBOPTIMAL REDUCTION OF ADVANCED OVARIAN CANCER

A team of researchers of the Multidisciplinary Unit of Abdominal and Pelvic Oncology Surgery (UMCOAP) at the Hospital General Universitari de Castelló, the Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO) and the Department of Medicine at the Universitat Jaume I (UJI) have designed a software capable of predicting if the ovarian cancer surgery will imply the entire elimination of the tumor in the abdominal cavity.

Technological offer

MEASUREMENT DEVICE FOR URINE DISCHARGE

Researchers at the Miguel Hernández University of Elche and the Sant Joan d’Alacant Hospital have developed a measurement device for the maximum urinary discharge consisting of a collection container, a measuring pipe and a disposable testing strip for measurement and registration.

 

Technological offer

In vitro METHOD TO DIAGNOSE A Pneumocystis jirovecii INFECTION

 

The method developed, based on a real time qPCR, permits obtaining a much faster (between 1 and 2 hours) and reliable result, as the contamination options are reduced. In addition, this technique permits quantifying the pathogen and has higher sensitivity.

 

Technological offer

REDUCCION DE TRANSMISIÓN DE VIBRACIÓN EN INCUBADORAS

Research staff from the Universitat Politècnica de València and the Foundation for the Promotion of Health and Biomedical Research of the Valencian Community FISABIO has developed a methodology to measure the vibrations transmitted to newborns inside incubators to propose the most appropriate solutions.

Ficha tecnológica 

METHOD FOR EARLY DIAGNOSIS OF GLAUCOMA

Researchers from the Universitat Politècnica de València, Universitat de València and the Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) have developed an in vitro method for the early detection, diagnosis and prognosis of POAG using a tear sample. The method also allows follow-up in patients already diagnosed.

Technology offer

 

NANOPARTICLES FOR THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS

Researchers from the Universitat Politècnica de València, Universitat de València and the Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) have developed an in vitro method for the early detection, diagnosis and prognosis of POAG using a tear sample. The method also allows follow-up in patients already diagnosed.

Technology sheet

BACTERIOPHAGY FOR THE PREVENTION AND TREATMENT OF MENTAL DISORDERS

Researchers from the Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio), the Universitat de València, the Institut d'Investigació Biomèdica de Girona of the Universitat Pompeu Fabra, and the Centro de Investigación Biomédica en Red CIBER, have patented a caudoviral bacteriophage, phage 936 from Lactococcus lactis, which can help alleviate cognitive disorders caused by other diseases.

Technology sheet

 

CALYSAP2020: SISTEMA DE INFORMACIÓN BASADO EN MODELOS CONCEPTUALES PARA LA GESTIÓN EFICIENTE Y SEGURA DE DATOS DE UNIDADES DE MEDICINA NUCLEAR Y RADIOFARMACIA

Researchers from the Universitat Politècnica de València and the Hospital Universitario Doctor Peset (FISABIO) have developed CalysapFénix, a software that improves and replaces the current information system (Calysap). The new IS is a double innovation: from the clinical point of view, it is a unique tool that improves the quality of information and traceability of the entire MN and RF process, with the consequent improvement of safety and quality in patient care; and from the point of view of technological innovation, it applies conceptual modelling and explainable artificial intelligence (EAI) techniques for its design, development and maintenance.

 

Ficha tecnológica

TOOL FOR THE AUTOMATIC DETECTION OF PATHOLOGIES IN CHEST RADIOGRAPHIES AND VALIDATION FROM AUTOMATIC ANALYSIS OF MEDICAL RECORDS

Software to support radiodiagnosis based on artificial intelligence (AI) computing techniques and the processing of large volumes of data (big data). The software consists of a module for the detection of pathologies in PA chest radiographs and associated reports to be used in production environments.